Betts Michael R, Exley Barbara, Price David A, Bansal Anju, Camacho Zenaido Tres, Teaberry Vanessa, West Sadie M, Ambrozak David R, Tomaras Georgia, Roederer Mario, Kilby J Michael, Tartaglia Jim, Belshe Robert, Gao Feng, Douek Daniel C, Weinhold Kent J, Koup Richard A, Goepfert Paul, Ferrari Guido
Laboratory of Immunology, Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 40 Convent Drive, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4512-7. doi: 10.1073/pnas.0408773102. Epub 2005 Mar 7.
Worldwide HIV-1 vaccine efforts are guided by the principle that HIV-specific T cell responses may provide protection from infection or delay overt disease. However, no clear correlates of T cell-mediated immune protection have been identified. Here, we examine in a HLA-B27(+) HIV seronegative vaccinee persistent HIV-specific vaccine-induced anti-Gag CD4(+) and CD8(+) T cell responses. Although these responses exhibited those characteristics (multifunctionality, appropriate memory phenotype, and targeting of epitopes associated with long-term nonprogression) predicted to correlate with protection from infection, the subject became HIV infected. After HIV infection, the vaccine-induced CD8(+) T cells expanded, but both CD4(+) and CD8(+) T cell responses acquired the functional and phenotypic patterns characteristic of chronic HIV infection. The virus quickly escaped the vaccine-induced T cell response, and the subject progressed more rapidly than expected for someone expressing the HLA-B27 allele. These data suggest that control of HIV by vaccine-elicited HIV-specific T cell responses may be difficult, even when the T cell response has those characteristics predicted to provide optimal protection.
全球范围内的HIV-1疫苗研发工作遵循着这样一个原则:针对HIV的特异性T细胞反应可能会提供抗感染保护或延缓显性疾病的发生。然而,尚未确定T细胞介导的免疫保护的明确相关因素。在此,我们对一名HLA-B27(+)的HIV血清阴性疫苗接种者体内持续存在的HIV特异性疫苗诱导的抗Gag CD4(+)和CD8(+) T细胞反应进行了研究。尽管这些反应表现出了那些预计与抗感染保护相关的特征(多功能性、适当的记忆表型以及针对与长期非进展相关的表位),但该受试者仍感染了HIV。HIV感染后,疫苗诱导的CD8(+) T细胞扩增,但CD4(+)和CD8(+) T细胞反应均获得了慢性HIV感染的功能和表型模式。病毒迅速逃脱了疫苗诱导的T细胞反应,并且该受试者的病情进展速度比表达HLA-B27等位基因的人预期的要快。这些数据表明,即使T细胞反应具有预计能提供最佳保护的特征,通过疫苗诱导的HIV特异性T细胞反应来控制HIV可能也很困难。